Colorectal cancer screening is a procedure used to detect cancer and pre-cancerous growths or polyps in the colon and rectum early. Common screening methods include fecal occult blood test, sigmoidoscopy, colonoscopy and double-contrast barium enema. Colorectal cancer screening helps in finding precancerous polyps so they can be removed before turning into cancer and detecting any cancer early when treatment works best. The screening can also catch cancers at an early stage, before they have spread, which often makes them easier to treat. With screening tests, more people are diagnosed and treated for colorectal cancer and the cancer death rate continues to decline.

The Global Colorectal Cancer Screening Market Size is estimated to be valued at US$ 5,952.2 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the U.S. Colorectal Cancer Screening are Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation And Novigenix SA. These players are involved in development and commercialization of screening tests for colorectal cancer detection. For instance, in 2021, Eiken Chemical launched EIKEN FOB Immunological Fecal Occult Blood Test to detect colorectal cancer at an early stage.

The demand for colorectal cancer screening is increasing significantly owing to rising prevalence of colorectal cancer and initiatives by government and non-government organizations to raise awareness regarding early cancer detection. As per American Cancer Society, in 2022, around 149,500 new cases of colorectal cancer were diagnosed and approximately 52,980 people will die from the cancer in the U.S.

Technological advancements are also fueling the market growth. Newer screening techniques such as CT colonography and stool DNA tests are being studied to improve the accuracy and compliance rates of colorectal cancer screening. Stool DNA test such as Cologuard by Exact Sciences is a non-invasive screening test approved by FDA in 2014 to detect colorectal cancer.

Market Trends

The uptake of minimally invasive procedures: The adoption of minimally invasive procedures such as colonoscopies is increasing rapidly owing to advantages such as reduced procedural pain, shorter recovery time and hospital stay. This trend will continue to drive the colorectal cancer screening market.

Personalized screening based on individual risk: There is a shift towards more personalized screening approaches based on individual patient's risk factors, family history, medical conditions and lifestyle habits. This helps in improving the effectiveness of screening by targeting high-risk individuals.

Market Opportunities

Incorporation Of AI And Machine Learning: AI and machine learning technologies are being integrated with screening diagnosis to increase diagnostic accuracy and automate parts of screening process. This presents significant growth opportunity for players.

Geographic Expansion: Players are expanding their geographic footprint and presence across emerging markets through partnerships, distribution agreements and acquisitions to tap the growing screening demand from these regions.

Impact of COVID-19 on U.S. Colorectal Cancer Screening market

The COVID-19 pandemic has adversely impacted the U.S. colorectal cancer screening market in the short term. During the peak of the pandemic in 2020 and early 2021, cancer screenings significantly declined as patients avoided hospitals and clinics due to fear of virus exposure. This led to a drop in new cases identified. However, as vaccination rates increased and safety protocols were widely adopted, screening volumes gradually recovered through 2021 and are approaching pre-pandemic levels. There is growing concern that delays in screenings may lead to increased late-stage diagnoses and poorer outcomes in the long run. To address this backlog, healthcare providers have implemented stricter screening guidelines and expanded capacities. Telehealth solutions are also being leveraged more for consultations to safely monitor at-risk groups. Going forward, sustained awareness campaigns and emphasis on preventive care will be critical to fulfill unmet screening needs and support the market's return to its previous growth trajectory in the forecast period.

In terms of geographical concentration, the Western region holds the major share of the U.S. colorectal cancer screening market currently in terms of value. This is attributed to states like California, Washington and Oregon that have highest uptake of screening tests. The Southern region, comprising Texas, Florida and other states, has emerged as the fastest growing regional market over the past few years. Rising health expenditures and focus on early detection have fueled market expansion in this area. The Northeast and Midwest regions are also significant contributors that will sustain high demand for screening services.

What Are The Key Data Covered In This U.S. Colorectal Cancer Screening Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the U.S. Colorectal Cancer Screening Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the U.S. Colorectal Cancer Screening Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- U.S. Colorectal Cancer Screening Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of U.S. Colorectal Cancer Screening Market vendors

FAQ’S

Q.1 What are the main factors influencing the U.S. Colorectal Cancer Screening market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top U.S. Colorectal Cancer Screening Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the U.S. Colorectal Cancer Screening market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

Get more insights on this topic: https://www.pressreleasebulletin.com/u-s-colorectal-cancer-screening-market-trend-size-and-demand/